scholarly journals Pityriasis Rosea after Moderna mRNA ‐1273 vaccine: a case series

2021 ◽  
Author(s):  
Martora Fabrizio ◽  
Gabriella Fabbrocini ◽  
Claudio Marasca
Keyword(s):  
Case Series ◽  
Pityriasis Rosea

scholarly journals A case series of erythema multiforme-like pityriasis rosea

2016 ◽  
Vol 7 (3) ◽  
pp. 212 ◽  
Author(s):  
Anupam Das ◽  
TusharK Sarkar ◽  
Somodyuti Chandra ◽  
Anupama Ghosh ◽  
RameshChandra Gharami
Keyword(s):  
Erythema Multiforme ◽  
Case Series ◽  
Pityriasis Rosea

scholarly journals Pityriasis rosea following SARS‐CoV‐2 vaccination: A case series

2021 ◽  
Author(s):  
Selami Aykut Temiz ◽  
Ayman Abdelmaksoud ◽  
Recep Dursun ◽  
Koray Durmaz ◽  
Roxanna Sadoughifar ◽  
...  
Keyword(s):  
Case Series ◽  
Pityriasis Rosea

scholarly journals Molecular Study of COVID-19 and its Relationship to Pityriasis Rosea

2021 ◽  
pp. 1-4
Author(s):  
Ahmed Abdulhussein Kawen ◽  
Keyword(s):  
Skin Disease ◽  
Statistical Difference ◽  
Clinical Symptoms ◽  
Age Distribution ◽  
Case Series ◽  
Molecular Study ◽  
Emergency Unit ◽  
Pityriasis Rosea ◽  
Significant Statistical Difference ◽  
New Type

Background: A new type of coronavirus family (SARS-CoV-2), that has been detected in individuals with several clinical symptoms named (COVID-19), was recognized as a pandemic on March 11, 2020. Numerous researches have been conducted on manifestations of skin disease related to COVID-19, i.e.rashes, pityriasis rosea (PR), vascular markings, and lesions as pimple-like. Aim: This study aims to find out if the Coronavirus can affect (PR) development which also can be considered as a trigger and symptom for other types of infections. Material and Methods: A case series descripting the dermatological finding of COVID-19 in Thi-Qar Governorate, a collective sample taking from inpatients, outpatients, the emergency unit of Al Hussein Teaching Hospital, and inwards of Al-Shefaa’ Isolation Hospital. The study has been done over a four-month period (June-September, 2020.) Results: 19 patients (10 females and 9 males), who have infected with Coronavirus and were suffering from (PR), are included in this study. The highest percentage of females 52.6% and males 47.4%. The distribution of patients according to the incidence of (PR) in typical and anomalous manners had the percentage of typical 77.9% and abnormal 21.1%. The highest percentage was in moderate Covid-19 (84.2%), while it was 15.8% in mild Covid-19. There was no significant statistical difference in mean age distribution according to gender while there were significant statistical differences according to (PR) and COVID-19 class. More studies are needed to evaluate whether or not these lesions are associated with the virus. Conclusion: The (PR) was one of the dermatological finding of COVID-19, that did not have a clear role in the distribution of the disease according to the background of the patients and also the severity of COVID-19. It can be triggered by COVID-19 and completely cured with the clearance of the disease. Recommendation: An accurate robust cutaneous documentation related to Covid19 is required to increase the knowledge of disease as well as its epidemiology

Vesicular pityriasis rosea

1977 ◽  
Vol 113 (12) ◽  
pp. 1733b-1734 ◽  
Author(s):  
A. Griffiths
Keyword(s):  
Pityriasis Rosea

Abstract #856 A Case Series Review of Clinical and Biochemical Characteristics of Pituitary Abcess in Mexican Patients

2018 ◽  
Vol 24 ◽  
pp. 202-203
Author(s):  
Mireya Perez-Guzman ◽  
Alfredo Nava de la Vega ◽  
Arturo Pena Velarde ◽  
Tania Raisha Torres Victoria ◽  
Froylan Martinez-Sanchez ◽  
...  
Keyword(s):  
Case Series ◽  
Biochemical Characteristics ◽  
Mexican Patients

Cannabis-associated arteritis

VASA ◽  
2010 ◽  
Vol 39 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Grotenhermen
Keyword(s):  
Systematic Review ◽  
Case Reports ◽  
Case Series ◽  
Cardiovascular Effects ◽  
Causative Factor ◽  
Cannabis Use ◽  
Thromboangiitis Obliterans ◽  
Pathological Features ◽  
Scientific Support ◽  
Clinical And Pathological Features

Background: To investigate the hypothesis that cases of arteritis similar to thromboangiitis obliterans (TAO) and associated with the use of cannabis were caused by cannabis or THC (dronabinol), or that cannabis use is a co-factor of TAO. Patients and methods: A systematic review on case reports and the literature on so-called cannabis arteritis, TAO, and cardiovascular effects of cannabinoids was conducted. Results: Fifteen reports with 57 cases of an arteritis associated with the use of cannabis and two additional case series of TAO, in which some patients also used cannabis, were identified. Clinical and pathological features of cannabis-associated arteritis do not differ from TAO and the major risk factor of TAO, tobacco use, was present in most, if not in all of these cases. The proposed pathophysiological mechanisms for the development of an arteritis by cannabis use are not substantiated. Conclusions: The hypothesis of cannabis being a causative factor or co-factor of TAO or an arteritis similar to TAO is not supported by the available evidence. The use of the term “cannabis arteritis” should be avoided until or unless more convincing scientific support is forthcoming.

Sign in / Sign up

Export Citation Format

Share Document